Inflammatory and stress markers predicting pneumonia, outcome, and etiology in patients with stroke
Biomarkers for predicting pneumonia, functional outcome, and death after stroke
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 15, 2019
- Accepted in final form January 27, 2020
- First Published February 25, 2020.
Author Disclosures
- Benjamin Hotter, MD,
- Sarah Hoffmann, MD,
- Lena Ulm, MD,
- Joan Montaner, MD,
- Alejandro Bustamante, MD,
- Christian Meisel, MD and
- Andreas Meisel, MD
- Benjamin Hotter, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sarah Hoffmann, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Sarah Hoffmann reveived speaker's honoraria fromme Alexion pharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lena Ulm, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joan Montaner, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alejandro Bustamante, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
AB is supported by a Juan Rodés research contract JR16/00008 from the Instituto de Salud Carlos III
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian Meisel, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andreas Meisel, MD
NONE
NONE
1) commercial, Alexion, speaker honoraria 2) commercial, GRIFOLS, speaker honoraria 3) commercial, Novartis, speaker honoraria 4) commercial, Hormosan, speaker honoraria 5) commercial, Pfizer, speaker honoraria
1) BMC Neurology, Section Editor, 2015- 4) European Stroke Journal, Editor, 2019 -
NONE
NONE
NONE
1) commercial, Alexion, MorphoSys, Bayer AG, Vitaccess 2) non-profit entity, German Myasthenia Gravis Society (Deutsche Myasthenie Gesellschaft)
1) commercial, Frau Schneider GmbH
NONE
NONE
1) Octapharma 2) Alexion
1) Deutsche Forschungsgemeinschaft, NeuroCure Cluster of Excellence, Exc 257, PI, 10 years 2) Deutsche Forschungsgemeinschaft, Collaborative Research Centres SFB-TRR 167, PI, 4 years 3) Deutsche Forschungsgemeinschaft, Collaborative Research Centres SFB-TRR 84, PI, 8 years 4)Bundesministerium für Bildung und Forschung, Center for Stroke Research Berlin, 01 EO 08 01, PI, 6 years
NONE
1)Einstein-Foundation (A-2017-406) 2)Fondation Leducq Transatlantic Networks of Excellence
NONE
NONE
NONE
NONE
NONE
NONE
- From the Charité - Universitätsmedizin Berlin (B.H., S.H., L.U., A.M.), Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Center for Stroke Research Berlin, NeuroCure Clinical Research Center and Department of Neurology, Berlin; Friedrich Loeffler Institute of Medical Microbiology (L.U.), University Medicine Greifswald, Greifswald, Germany; Neurovascular Research Laboratory (J.M., A.B.), Vall d’Hebron Institut de Recerca, Barcelona; Stroke Research Program (J.M.), Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville; Department of Neurology (J.M.), Hospital Universitario Virgen Macarena, Spain; and Department of Medical Immunology (C.M.), Charité University Medicine and Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
- Correspondence
Dr. Hotter benjamin.hotter{at}charite.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic strokeWen-Jun Tu, Guo-Zhao Ma, Ying Ni et al.Neurology, April 19, 2017 -
Article
Copeptin adds prognostic information after ischemic strokeResults from the CoRisk studyGian Marco De Marchis, Mira Katan, Anja Weck et al.Neurology, March 06, 2013 -
Articles
Predictors of major neurologic improvement after thrombolysis in acute strokeGustavo Saposnik, Silvia Di Legge, Fiona Webster et al.Neurology, October 24, 2005 -
Article
A novel biomarker-based prognostic score in acute ischemic strokeThe CoRisk scoreGian Marco De Marchis, Theresa Dankowski, Inke R. König et al.Neurology, March 01, 2019